164 related articles for article (PubMed ID: 8413311)
1. Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site.
Dorssers LC; van Agthoven T; Dekker A; van Agthoven TL; Kok EM
Mol Endocrinol; 1993 Jul; 7(7):870-8. PubMed ID: 8413311
[TBL] [Abstract][Full Text] [Related]
2. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells.
van Agthoven T; van Agthoven TL; Dekker A; van der Spek PJ; Vreede L; Dorssers LC
EMBO J; 1998 May; 17(10):2799-808. PubMed ID: 9582273
[TBL] [Abstract][Full Text] [Related]
3. Genetic mechanisms of estrogen-independence in breast cancer.
Dorssers LC; van Agthoven T
Pathol Res Pract; 1996 Jul; 192(7):743-51. PubMed ID: 8880875
[TBL] [Abstract][Full Text] [Related]
4. Functional identification of genes causing estrogen independence of human breast cancer cells.
van Agthoven T; Veldscholte J; Smid M; van Agthoven TL; Vreede L; Broertjes M; de Vries I; de Jong D; Sarwari R; Dorssers LC
Breast Cancer Res Treat; 2009 Mar; 114(1):23-30. PubMed ID: 18351453
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells.
Dorssers LC; Veldscholte J
Int J Cancer; 1997 Aug; 72(4):700-5. PubMed ID: 9259413
[TBL] [Abstract][Full Text] [Related]
6. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
[TBL] [Abstract][Full Text] [Related]
7. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.
Brinkman A; van der Flier S; Kok EM; Dorssers LC
J Natl Cancer Inst; 2000 Jan; 92(2):112-20. PubMed ID: 10639512
[TBL] [Abstract][Full Text] [Related]
8. Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response.
van Agthoven T; Sieuwerts AM; Meijer D; Meijer-van Gelder ME; van Agthoven TL; Sarwari R; Sleijfer S; Foekens JA; Dorssers LC
Endocr Relat Cancer; 2010 Mar; 17(1):215-30. PubMed ID: 19966015
[TBL] [Abstract][Full Text] [Related]
9. Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum(II) resistance.
Lu SJ; Man S; Bani MR; Adachi D; Hawley RG; Kerbel RS; Ben-David Y
Cancer Res; 1995 Mar; 55(5):1139-45. PubMed ID: 7867000
[TBL] [Abstract][Full Text] [Related]
10. Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells.
Meijer D; van Agthoven T; Bosma PT; Nooter K; Dorssers LC
Mol Cancer Res; 2006 Jun; 4(6):379-86. PubMed ID: 16778085
[TBL] [Abstract][Full Text] [Related]
11. Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
van Agthoven T; Sieuwerts AM; Meijer-van Gelder ME; Look MP; Smid M; Veldscholte J; Sleijfer S; Foekens JA; Dorssers LC
J Clin Oncol; 2009 Feb; 27(4):542-9. PubMed ID: 19075277
[TBL] [Abstract][Full Text] [Related]
12. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
Zhang L; Kharbanda S; Hanfelt J; Kern FG
Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
[TBL] [Abstract][Full Text] [Related]
13. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J
Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of acquired antiestrogen resistance and its management in breast cancer].
Iino Y; Maemura M; Morishita Y
Nihon Rinsho; 1997 May; 55(5):1149-54. PubMed ID: 9155167
[TBL] [Abstract][Full Text] [Related]
15. Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line.
Matzner I; Savelyeva L; Schwab M
Cancer Lett; 2003 Jan; 189(2):207-19. PubMed ID: 12490314
[TBL] [Abstract][Full Text] [Related]
16. Genetic screening reveals an essential role of p27kip1 in restriction of breast cancer progression.
Yuan Y; Qin L; Liu D; Wu RC; Mussi P; Zhou S; Songyang Z; Xu J
Cancer Res; 2007 Sep; 67(17):8032-42. PubMed ID: 17804714
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
18. NFκB signaling is important for growth of antiestrogen resistant breast cancer cells.
Yde CW; Emdal KB; Guerra B; Lykkesfeldt AE
Breast Cancer Res Treat; 2012 Aug; 135(1):67-78. PubMed ID: 22527100
[TBL] [Abstract][Full Text] [Related]
19. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.
Vickers PJ; Dickson RB; Shoemaker R; Cowan KH
Mol Endocrinol; 1988 Oct; 2(10):886-92. PubMed ID: 3185565
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
